Herbert Smith Freehills‘ corporate partners James Palmer and Gillian Fairfield have taken the UK lead on US drugmaker AbbVie’s proposed $51bn takeover of Ireland’s Shire Pharmaceuticals, which has selected Magic Circle firm Slaughter and May.
AbbVie upped its bid for Shire, which is listed on the London Stock Exchange, from $46bn to $51bn earlier this week after Shire felt the previous offer significantly undervalued its business, which has built up a more diverse rare diseases division in recent years.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact jasmine.glass@legalbusiness.co.uk
